Dermatology
Handbook of Systemic Drug Treatment in Dermatology 2023
The Handbook of Systemic Drug Treatment in Dermatology helps prescribers and patients make rational decisions about drug treatment while considering known risks and potential unwanted effects. Written for dermatologists, family practitioners, pharmacists and specialist nurses, this completely revised and updated third edition of a bestseller provides an accessible and concise aid to prescribing and monitoring systemic dermatologic therapy. For each drug or drug class, the book lists its classification, mode of action, formulations, dosages, suggested regimens, contraindications, important drug interactions, adverse effects, patient information, and more. This third edition includes new classes of drugs as well as information on updated guidelines for prescribing and monitoring established drugs.
FROM REVIEWS OF PREVIOUS EDITIONS
"This updated edition includes new arrivals… Quite simply, it is indispensable! I have it with me in every clinic and often refer to it in discussions with pharmacists (who have been known to borrow my copy and forget to return it)." Dermatology in Practice
"... an outstanding resource that helps to alleviate worrying by providing precise guidelines and advice in managing our most infirm patients who require these medications." SkinMed
Table of contents :
Cover
Half Title
Title Page
Copyright Page
Contents
Preface
Contributors
List of Abbreviations
Chapter 1: Acitretin
Chapter 2: Acne Antibiotics
Chapter 3: Alitretinoin
Chapter 4: Antiandrogens
Chapter 5: Antibiotics Commonly Used for Skin Infections
Chapter 6: Antifungals
Chapter 7: Antimalarials
Chapter 8: Antivirals for Herpesviruses
Chapter 9: Apremilast
Chapter 10: Azathioprine
Chapter 11: Azole Antihelminths
Chapter 12: Bexarotene
Chapter 13: Ciclosporin
Chapter 14: Colchicine
Chapter 15: Corticosteroids
Chapter 16: Cyclophosphamide
Chapter 17: Dapsone
Chapter 18: Dimethyl Fumarate
Chapter 19: Interleukin-4/13 Inhibitors
Chapter 20: Interleukin (IL)-12/23 and IL-23 Inhibitors
Chapter 21: Interleukin-17 Inhibitors
Chapter 22: Isotretinoin
Chapter 23: Ivermectin
Chapter 24: Intravenous Immunoglobulin
Chapter 25: Janus Kinase (JAK) Inhibitors
Chapter 26: Malignant Melanoma Drug Treatments
Chapter 27: Methotrexate
Chapter 28: Mycophenolate Mofetil
Chapter 29: Omalizumab
Chapter 30: Potassium Iodide
Chapter 31: Propranolol
Chapter 32: Psoralens
Chapter 33: Rituximab
Chapter 34: Sulfapyridine and Sulfamethoxypyridazine
Chapter 35: Thalidomide
Chapter 36: Tumour Necrosis Factor Antagonists
Chapter 37: Vismodegib
Chapter 38: Systemic Therapy in Children and Young People
Chapter 39: Systemic Therapy and Kidney Disease
Chapter 40: Systemic Therapy and Liver Disease
Chapter 41: Systemic Therapy in Older People
